Back

H-HeFT: Hydralazin-Isosorbide Dinitrate in HFrEF

30 August 2026 (08:15 - 08:25)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

14 More presentations in this session

Presentation thumbnail
H-ISDN Meta-Analysis: Hydralazine-Isosorbide Dinitrate in HFrEF
Doctor J. Butt (Copenhagen, DK)
Presentation thumbnail
Discussant review - H-HeFT, H-ISDN Meta-Analysis
Professor J. McMurray (Glasgow, GB)
Presentation thumbnail
Panel discussion - H-HeFT, H-ISDN Meta-Analysis
Presentation thumbnail
Met-HeFT: Metformin and chronic heart failure
Professor H. Wiggers (Aarhus, DK)
Presentation thumbnail
Met-HeFT meta-analysis: Metformin in heart failure and ischemic heart disease: a systematic review and meta-analyses
Associate Professor A. Larsen (Herning, DK)

Access the full session

Session thumbnail
HOT LINE 6

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Webinar
Clinical trials and highlights from 2021
28 February 2022
thumbnail
Congress Presentation
Exploring the clinical and mechanistic impacts of the nitroxyl donors on heart failure management: a meta-analysis of hemodynamics effects and safety
31 August 2025
thumbnail
Congress Session
Improving patient outcomes in heart failure: the role of finerenone
19 May 2025
thumbnail
Congress Presentation
Is it safe to initiate four medications in four weeks for HFrEF patients in a normal practice. The experience of a heart failure centre.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources